LRRK2; a dynamic regulator of cellular trafficking

Area of Science:

• Neurodegenerative Disorders
• Molecular Pathogenesis
• Genetics of Neurological Diseases

Background:

• Parkinson's disease (PD) is the second most common neurodegenerative disorder, presenting motor and non-motor symptoms.
• The exact cause of PD remains unknown, with genetic, environmental, and inflammatory factors potentially playing roles.
• Genetic variations in leucine-rich repeat kinase 2 (LRRK2) are a significant risk factor for parkinsonism, clinically similar to idiopathic PD.

Purpose of the Study:

• To review the known biological functions of LRRK2.
• To explore the potential role of LRRK2 in the molecular pathogenesis of Parkinson's disease.
• To question how LRRK2 biology might influence synaptic dysfunction and neurodegeneration.

Main Methods:

• Literature review of existing studies on LRRK2 and Parkinson's disease.
• Analysis of pathological findings in LRRK2-parkinsonism.
• Synthesis of evidence regarding LRRK2's cellular functions and potential link to PD.

Main Results:

• LRRK2 genetic variability confers substantial risk for parkinsonism.
• Pathology in LRRK2-parkinsonism can involve alpha-synuclein or tau accumulation, or dopaminergic neuron loss.
• LRRK2 is implicated in sensing endosomal trafficking and regulating vesicular flux and cytoskeletal dynamics.

Conclusions:

• Synaptic and axonal dysfunction may precede dopaminergic neuron loss in PD.
• LRRK2's cellular functions, particularly in endosomal trafficking, may be critical in the early stages of PD pathogenesis.
• Further investigation into LRRK2's molecular mechanisms is warranted to understand its influence on PD.